DCDC Health Services Pvt. Ltd., operating dialysis centers under the brand DCDC Kidney Care, has announced a strategic investment of ₹82 crore (approximately $10 million) from British International Investment (BII), the UK’s development finance institution and impact investor.
This funding aims to enhance access to life-saving dialysis treatments for low-income patients suffering from end-stage renal disease (ESRD).
Expanding Access Through the PPP Model
DCDC Kidney Care has established itself as a provider of dialysis services through public-private partnerships (PPP) with state governments. This approach focuses on delivering affordable and high-quality treatments to economically weaker sections of society, addressing the critical healthcare gap in renal care.
Scaling Operations for Greater Impact
The startup plans to deploy 900 dialysis machines across more than 100 centers within the next three years. This expansion is expected to benefit over 15,000 unique patients, the majority of whom belong to low-income demographics. Additionally, the initiative will generate approximately 1,000 direct jobs, supporting both healthcare accessibility and economic development.
BII’s Commitment to Impact Investments
British International Investment has reiterated its commitment to financing projects with social and environmental impact. Between 2022 and 2026, at least 30% of BII’s total new commitments will be directed toward climate finance. BII’s current portfolio includes investments in over 1,580 businesses across 65 countries, underlining its global reach and impact.
Bridging Critical Gaps in Healthcare
DCDC Kidney Care’s partnership with BII not only bolsters its growth plans but also aligns with a broader mission of improving healthcare equity in India. By addressing the needs of underserved populations, the collaboration seeks to redefine dialysis care and contribute to a more inclusive healthcare ecosystem.
